Concepedia

Lynda J. Krasenbaum

LJ

3

Publications

83

Citations

3

H-Index

2021

Active since

Affiliations

Teva Pharmaceuticals (United States)(Current)

Teva Pharmaceuticals (Netherlands)

Lynda J. Krasenbaum is an author at Teva Pharmaceuticals (United States).

Publications per year

2021–2022

3

Publications

3

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States

Peter McAllister, Lois Lamerato, Lynda J. Krasenbaum et al. · The Journal of Headache and Pain · 2021 · 34 citations · Full text

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

Stephanie J. Nahas, Steffen Naegel, Joshua M. Cohen et al. · The Journal of Headache and Pain · 2021 · 28 citations · Full text

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Lynda J. Krasenbaum, V. Pedarla, Stephen F. Thompson et al. · The Journal of Headache and Pain · 2022 · 21 citations · Full text

Rows per page

1–3 of 3